🇺🇸 FDA
Patent

US 7745489

Compositions and methods for inhibition of phospholipase A2 mediated inflammation

granted A61PA61P25/04A61P29/00

Quick answer

US patent 7745489 (Compositions and methods for inhibition of phospholipase A2 mediated inflammation) held by The Regents of the University of California expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P25/04, A61P29/00, A61P43/00